Stockscreener 앱 받기
8.92
1.87%
-0.17
시장 영업 전:
9.92
1.00
+11.21%
Carlsmed Inc 주식(CARL)의 최신 뉴스
BTIG Research Reiterates Buy Rating for Carlsmed (NASDAQ:CARL) - MarketBeat
Zimmerman Reiterates Buy on Carlsmed After Strong Q1, Raises 2026 Outlook and Keeps $23 Price Target Unchanged - TipRanks
Carlsmed (CARL) Q1 2026 Earnings Transcript - AOL.com
Carlsmed Earnings Call Highlights Growth, Rising Costs - TipRanks
Carlsmed Q1 Earnings Call Highlights - Yahoo Finance
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Carlsmed Q1 2026 shows strong revenue growth - Investing.com
Carlsmed (NASDAQ:CARL) Shares Surge on Q1 Earnings Beat and Raised Full-Year Guidance - ChartMill
Carlsmed Q1 2026 Earnings Call Transcript - MarketBeat
Carlsmed® Reports First Quarter 2026 Financial Results - The Manila Times
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Carlsmed, Inc. (NASDAQ:CARL) Sees Large Drop in Short Interest - MarketBeat
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - The Manila Times
Carlsmed (CARL) Stock Outlook | Q4 2025: Profit Exceeds ViewsInvestment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Carlsmed (CARL) Stock: Why Market Expansion (Slight Loss) 2026-04-16Trending Volume Leaders - UBND thành phố Hải Phòng
Carlsmed, Inc. (NASDAQ:CARL) Short Interest Up 23.4% in March - MarketBeat
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛
CARL Maintains Buy Rating -- Price Target Lowered to $18.00 by T - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Cut to $18.00 by Analysts at Truist Financial - MarketBeat
Truist Financial Maintains Carlsmed(CARL.US) With Buy Rating, Cuts Target Price to $18 - 富途牛牛
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Cuts Target Price to $23 - 富途牛牛
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times
Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf - Yahoo Finance
The Goldman Sachs Group Has Lowered Expectations for Carlsmed (NASDAQ:CARL) Stock Price - Defense World
Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat
CARL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CARL.O PE Ratio & Valuation, Is CARL.O Overvalued - Intellectia AI
CARL Technical Analysis & Stock Price Forecast - Intellectia AI
CARL News & Events - Intellectia AI
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference - The Manila Times
CARL Stock Analysis: Carlsmed Inc medical tech gains 6.41 percent trading at 9.63 - Cổng thông tin điện tử tỉnh Lào Cai
Carlsmed (NASDAQ:CARL) Upgraded at Zacks Research - Defense World
Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating - MarketBeat
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts - MarketBeat
Carlsmed reports Q4, FY 2025 revenue above estimate - MSN
Carlsmed, Inc.: Fundamental Analysis and Financial Ratings | I82 | US14280C1053 - marketscreener.com
Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal
Carlsmed joins Russell 2000 Index following Q3 IPO - MSN
Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World
Comparing Carlsmed (CARL) & The Competition - Defense World
Head to Head Review: Carlsmed (CARL) and The Competition - Defense World
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN
Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World
Carlsmed unveils custom cervical plating tech - MSN
Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World
1.66%
1.60%
자본화:
|
볼륨(24시간):